<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> multifactorial disorder </plain></SENT>
<SENT sid="1" pm="."><plain>Although epidemiological data from twin and family studies provide substantial evidence for a genetic basis for <z:hpo ids='HP_0001297'>stroke</z:hpo>, the contribution of genetic factors identified so far is small </plain></SENT>
<SENT sid="2" pm="."><plain>Large progress has been made in single-gene disorders associated with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, particularly at young age </plain></SENT>
<SENT sid="3" pm="."><plain>The identification of NOTCH3 mutations in patients with cerebral <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> with subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and leucoencephalopathy (CADASIL) and of TREX1 mutations in <z:chebi fb="46" ids="15035">retinal</z:chebi> vasculopathy with cerebral <z:hpo ids='HP_0002415'>leukodystrophy</z:hpo> (RVCL) have led to new insights on lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> and small-vessel disease </plain></SENT>
<SENT sid="4" pm="."><plain>Studies of <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle-cell disease</z:e> have drawn attention to the importance of modifier genes and of gene-gene interactions in determining <z:hpo ids='HP_0001297'>stroke</z:hpo> risk, while there is now evidence that <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> is an underdiagnosed cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, <z:hpo ids='HP_0001297'>stroke</z:hpo> is a well-known complication of several <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorders</z:e>, including <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (FBN1 mutations) and <z:e sem="disease" ids="C0268338" disease_type="Disease or Syndrome" abbrv="EDS4">Ehlers-Danlos syndrome type IV</z:e> (COL3A1 mutations), which predispose to cervical <z:e sem="disease" ids="C0002949" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">artery dissection</z:e>, the most frequent cause of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> at young age </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, little is known about the genes associated with multifactorial <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The reported genome-wide association studies of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> have shown that no single common genetic variant imparts major risk </plain></SENT>
<SENT sid="8" pm="."><plain>Pharmacogenomic studies have uncovered genetic determinants of response to <z:chebi fb="8" ids="10033">warfarin</z:chebi>, <z:chebi fb="0" ids="35664">statins</z:chebi> and <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Larger studies with samples numbering in the thousands are ongoing to identify common variants with smaller effects on risk </plain></SENT>
<SENT sid="10" pm="."><plain>This approach will contribute to the identification of additional genes, novel pathways, and eventually novel therapeutic approaches to cerebrovascular disorders </plain></SENT>
</text></document>